Jermy, B. R., Ravinayagam, V., Alamoudi, W. A., Almohazey, D., Dafalla, H., Hussain Allehaibi, L., . . . Somanathan, T. (2019). Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe(2)O(4)/silica/cisplatin nanocomposite formulation. Beilstein J Nanotechnol.
Stile di citazione ChicagoJermy, B Rabindran, Vijaya Ravinayagam, Widyan A. Alamoudi, Dana Almohazey, Hatim Dafalla, Lina Hussain Allehaibi, Abdulhadi Baykal, Muhammet S. Toprak, e Thirunavukkarasu Somanathan. "Targeted Therapeutic Effect against the Breast Cancer Cell Line MCF-7 With a CuFe(2)O(4)/silica/cisplatin Nanocomposite Formulation." Beilstein J Nanotechnol 2019.
Citazione MLAJermy, B Rabindran, et al. "Targeted Therapeutic Effect against the Breast Cancer Cell Line MCF-7 With a CuFe(2)O(4)/silica/cisplatin Nanocomposite Formulation." Beilstein J Nanotechnol 2019.